AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALGORAE PHARMACEUTICALS LTD

0.011

0.000

Volume:340

Turnover:4

Market Cap:22.25M

PE:-18.33

High:0.011

Open:0.011

Low:0.011

Close:0.011

52wk High:0.024

52wk Low:0.007

Shares:2.02B

Float Shares:1.05B

Volume Ratio:0.00

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.001

EPS(LYR):0.000

ROE:-47.38%

ROA:-39.62%

PB:11.77

PE(LYR):-22.04

Loading ...

Overview Company News Filings

Algorae Pharmaceuticals Ltd-nasdaq Pharma Chairman Troy Valentine Joins Algorae Board

THOMSON REUTERS

Algorae Pharmaceuticals Ltd-company Secretary Appointment/resignation

THOMSON REUTERS

Algorae Pharmaceuticals - Named Foundation Participant and Launch Partner in Sovereign AI Infrastructure Initiative

THOMSON REUTERS

Algorae Pharmaceuticals Ltd-change of Auditor

THOMSON REUTERS

BRIEF-Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma

Algorae Pharmaceuticals Ltd - Executes Licence & Supply Agreement With Torrent Pharmaceuticals for Two Generic Molecules in ANZ

THOMSON REUTERS

BRIEF-Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement

Algorae Pharmaceuticals - Agreement for 10 Products With Zydus Lifesciences for Australian and New Zealand Markets

THOMSON REUTERS

Algorae Pharmaceuticals Ltd-Algorae and Zydus Enter Exclusive Commercial Agreement

THOMSON REUTERS

BRIEF-Algorae Pharmaceuticals Raises A$3.9 Million At A$0.012 Per Share

Algorae Pharmaceuticals - Raises a$3.9M at a$0.012 per Share

THOMSON REUTERS

BRIEF-Algorae Pharmaceuticals Says TGA Accepts Initial Registration Dossier For Evaluation

Algorae Pharmaceuticals Ltd - Tga Accepts Initial Registration Dossier for Evaluation

THOMSON REUTERS

BRIEF-Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening Program

Companies Like Algorae Pharmaceuticals (ASX:1AI) Can Afford To Invest In Growth

Simply Wall St.

Algorae Pharmaceuticals Ltd-Appointment of Mr Waleed Elsayed as Head of Sales

THOMSON REUTERS

Algorae Pharmaceuticals Ltd-Algorae Appoints Mr David Gulland to Its Board of Directors

THOMSON REUTERS

BRIEF-Algorae Pharmaceuticals Signs License & Supply Agreement With Cadila

Algorae Pharmaceuticals Ltd - Agreement to Launch 2 Generic Medicines for Cardiovascular & Metabolic Disorders in Australia & New Zealand

THOMSON REUTERS

BRIEF-Algorae Pharmaceuticals Secures A$3 Million Debt Facility With Scotpac

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/1AI.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"1AI.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AI.AU\",,,,,undefined,":{"symbol":"1AI.AU","market":"AU","secType":"STK","nameCN":"ALGORAE PHARMACEUTICALS LTD","latestPrice":0.011,"timestamp":1787292720000,"preClose":0.011,"halted":0,"volume":340,"delay":0,"changeRate":0,"nameEN":"ALGORAE PHARMACEUTICALS LTD","floatShares":1046585658,"shares":2023070000,"eps":-0.0006,"marketStatus":"Market Closed","change":0,"latestTime":"08-21 16:12:00 AEST","open":0.011,"high":0.011,"low":0.011,"amount":4,"amplitude":0,"askPrice":0.012,"askSize":1225248,"bidPrice":0.011,"bidSize":566164,"shortable":3,"etf":0,"ttmEps":-0.0006,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.011,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.0006297807770161135,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"1AI.AU","preClose":0.01,"auctionPrice":0.011,"auctionVolume":288108,"auction":3,"marketStatus":"盘后竞价","timestamp":1787205603551}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AI.AU\",,,,,undefined,":{"symbol":"1AI.AU","floatShares":1046585658,"roa":"-39.62%","roe":"-47.38%","lyrEps":-0.000499,"volumeRatio":0.0006297807770161135,"shares":2023070000,"dividePrice":0,"high":0.011,"amplitude":0,"preClose":0.011,"low":0.011,"week52Low":0.007,"pbRate":"11.77","psRate":"-850.71","week52High":0.024,"institutionHeld":0,"latestPrice":0.011,"committee":-0.367913,"eps":-0.0006,"divideRate":0,"volume":340,"delay":0,"ttmEps":-0.0006,"open":0.011,"prevYearClose":0.014,"prevWeekClose":0.011,"prevMonthClose":0.012,"prevQuarterClose":0.01,"fiveDayClose":0.011,"twentyDayClose":0.013,"sixtyDayClose":0.012,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/1AI.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"1AI.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"1AI.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651482614","title":"Algorae Pharmaceuticals Ltd-nasdaq Pharma Chairman Troy Valentine Joins Algorae Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2651482614","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651482614?lang=en_us&edition=fundamental","pubTime":"2026-07-15 06:59","pubTimestamp":1784069998,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUE55XKCT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647879195","title":"Algorae Pharmaceuticals Ltd-company Secretary Appointment/resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2647879195","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647879195?lang=en_us&edition=fundamental","pubTime":"2026-06-30 14:19","pubTimestamp":1782800363,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUE2QX7MH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["1AI.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647349519","title":"Algorae Pharmaceuticals - Named Foundation Participant and Launch Partner in Sovereign AI Infrastructure Initiative","url":"https://stock-news.laohu8.com/highlight/detail?id=2647349519","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647349519?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:03","pubTimestamp":1782687803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645893078","title":"Algorae Pharmaceuticals Ltd-change of Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2645893078","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645893078?lang=en_us&edition=fundamental","pubTime":"2026-06-24 16:27","pubTimestamp":1782289644,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUE18PBLW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633733689","title":"BRIEF-Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2633733689","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633733689?lang=en_us&edition=fundamental","pubTime":"2026-05-06 06:55","pubTimestamp":1778021721,"startTime":"0","endTime":"0","summary":"BRIEF-Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent PharmaMay 6  - Algorae Pharmaceuticals Ltd 1AI.AX:1AI EXECUTES LICENSE & SUPPLY AGREEMENT WITH TORRENT PHARMAEXECUTES LICENCE SUPPLY AGREEMENT WITH TORRENT PHARMACEUTICALS FOR TWO GENERIC MOLECULES IN ANZFurther company coverage: 1AI.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUE9KSRKX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["1AI.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633973840","title":"Algorae Pharmaceuticals Ltd - Executes Licence & Supply Agreement With Torrent Pharmaceuticals for Two Generic Molecules in ANZ","url":"https://stock-news.laohu8.com/highlight/detail?id=2633973840","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633973840?lang=en_us&edition=fundamental","pubTime":"2026-05-06 06:54","pubTimestamp":1778021647,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUE9KSRKX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["1AI.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630342390","title":"BRIEF-Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2630342390","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630342390?lang=en_us&edition=fundamental","pubTime":"2026-04-28 09:17","pubTimestamp":1777339067,"startTime":"0","endTime":"0","summary":"BRIEF-Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial AgreementApril 28  - Algorae Pharmaceuticals Ltd 1AI.AX:ALGORAE AND ZYDUS ENTER EXCLUSIVE COMMERCIAL AGREEMENTAGREEMENT FOR 10 PRODUCTS WITH ZYDUS LIFESCIENCES FOR AUSTRALIAN AND NEW ZEALAND MARKETSFurther company coverage: 1AI.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nTUE7MWZW9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630345497","title":"Algorae Pharmaceuticals - Agreement for 10 Products With Zydus Lifesciences for Australian and New Zealand Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2630345497","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630345497?lang=en_us&edition=fundamental","pubTime":"2026-04-28 06:35","pubTimestamp":1777329350,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUE7MWZW9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["1AI.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630345482","title":"Algorae Pharmaceuticals Ltd-Algorae and Zydus Enter Exclusive Commercial Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2630345482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630345482?lang=en_us&edition=fundamental","pubTime":"2026-04-28 06:35","pubTimestamp":1777329350,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUE7MWZW9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624157047","title":"BRIEF-Algorae Pharmaceuticals Raises A$3.9 Million At A$0.012 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2624157047","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624157047?lang=en_us&edition=fundamental","pubTime":"2026-04-02 18:23","pubTimestamp":1775125417,"startTime":"0","endTime":"0","summary":"BRIEF-Algorae Pharmaceuticals Raises A$3.9 Million At A$0.012 Per ShareApril 2 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX:RAISES A$3.9M AT A$0.012 PER SHAREFurther company coverage: 1AI.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nFWN40K17U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624578575","title":"Algorae Pharmaceuticals - Raises a$3.9M at a$0.012 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2624578575","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624578575?lang=en_us&edition=fundamental","pubTime":"2026-04-02 14:09","pubTimestamp":1775110158,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nFWN40K17U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["1AI.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624525946","title":"BRIEF-Algorae Pharmaceuticals Says TGA Accepts Initial Registration Dossier For Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=2624525946","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624525946?lang=en_us&edition=fundamental","pubTime":"2026-04-02 09:15","pubTimestamp":1775092510,"startTime":"0","endTime":"0","summary":"BRIEF-Algorae Pharmaceuticals Says TGA Accepts Initial Registration Dossier For EvaluationApril 2 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX:TGA ACCEPTS INITIAL REGISTRATION DOSSIER FOR EVALUATIONFurther company coverage: 1AI.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nFWN40K1E9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624254764","title":"Algorae Pharmaceuticals Ltd -  Tga Accepts Initial Registration Dossier for Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=2624254764","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624254764?lang=en_us&edition=fundamental","pubTime":"2026-04-02 06:38","pubTimestamp":1775083135,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40K1E9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623647563","title":"BRIEF-Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2623647563","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623647563?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:41","pubTimestamp":1774834867,"startTime":"0","endTime":"0","summary":"BRIEF-Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening ProgramMarch 30  - Algorae Pharmaceuticals Ltd 1AI.AX:CO PARTNERS WITH PETER MACCALLUM CANCER CENTRE FOR SECOND AI-DRIVEN DRUG SYNERGY SCREENING PROGRAMFurther company coverage: 1AI.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nFWN40F0UE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622101122","title":"Companies Like Algorae Pharmaceuticals (ASX:1AI) Can Afford To Invest In Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2622101122","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622101122?lang=en_us&edition=fundamental","pubTime":"2026-03-25 04:00","pubTimestamp":1774382412,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-1ai/algorae-pharmaceuticals-shares/news/companies-like-algorae-pharmaceuticals-asx1ai-can-afford-to","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-1ai/algorae-pharmaceuticals-shares/news/companies-like-algorae-pharmaceuticals-asx1ai-can-afford-to","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620274177","title":"Algorae Pharmaceuticals Ltd-Appointment of Mr Waleed Elsayed as Head of Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2620274177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620274177?lang=en_us&edition=fundamental","pubTime":"2026-03-20 06:00","pubTimestamp":1773957627,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nTUE1WDSPB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618670574","title":"Algorae Pharmaceuticals Ltd-Algorae Appoints Mr David Gulland to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2618670574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618670574?lang=en_us&edition=fundamental","pubTime":"2026-03-10 05:57","pubTimestamp":1773093433,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nTUE4LDYW4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["1AI.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610503625","title":"BRIEF-Algorae Pharmaceuticals Signs License & Supply Agreement With Cadila","url":"https://stock-news.laohu8.com/highlight/detail?id=2610503625","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610503625?lang=en_us&edition=fundamental","pubTime":"2026-02-09 06:47","pubTimestamp":1770590879,"startTime":"0","endTime":"0","summary":"BRIEF-Algorae Pharmaceuticals Signs License & Supply Agreement With CadilaFeb 9  - Algorae Pharmaceuticals Ltd 1AI.AX:ALGORAE SIGNS LICENSE AND SUPPLY AGREEMENT WITH CADILASIGNS LICENSE AND SUPPLY AGREEMENT WITH CADILAAGREEMENT TO LAUNCH 2 GENERIC MEDICINES FOR CARDIOVASCULAR & METABOLIC DISORDERS IN AUSTRALIA & NEW ZEALANDFurther company coverage: 1AI.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260208:nFWN3Z21LL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610508219","title":"Algorae Pharmaceuticals Ltd - Agreement to Launch 2 Generic Medicines for Cardiovascular & Metabolic Disorders in Australia & New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2610508219","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610508219?lang=en_us&edition=fundamental","pubTime":"2026-02-09 06:02","pubTimestamp":1770588176,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260208:nFWN3Z21LL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605125729","title":"BRIEF-Algorae Pharmaceuticals Secures A$3 Million Debt Facility With Scotpac","url":"https://stock-news.laohu8.com/highlight/detail?id=2605125729","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605125729?lang=en_us&edition=fundamental","pubTime":"2026-01-21 09:37","pubTimestamp":1768959477,"startTime":"0","endTime":"0","summary":"BRIEF-Algorae Pharmaceuticals Secures A$3 Million Debt Facility With ScotpacJan 21 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX:SECURES A$3 MILLION DEBT FACILITY WITH SCOTPACFurther company coverage: 1AI.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YL0M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["1AI.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}